The company behind AMI has been fined by the Federal Court for failing to comply with orders that restrained it from making representations about the efficacy of its treatments NRM …

Capital Chemist Wanniassa has been awarded Capital Chemist Pharmacy of the Year, at the group’s annual end-of-year celebrations in Canberra This in-house award follows the announcement of six national pharmacies …

Trial of daily aspirin use for disease prevention in older Australians will receive part of $483 million in grants for health and medical research announced by the Minister for Health …

“The retort from many smokers recently to my QUIT message is to inform me that they are now vaping. I would like to be able to explain the risks and …

A new Cochrane review has found pharmacist prescribers are comparable to medical prescribers for chronic disease outcomes The review, led by the researchers from Monash University’s Faculty of Pharmacy and …

Debbie Rigby takes a look at the latest research news Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease In this large double-blind event-driven trial, ticagrelor (90 mg twice daily) was …

Pharmacists are much more likely than doctors to receive a regulatory penalty if they are subject to a notification for unsafe practice, new study reveals An analysis of all notifications …

Retail association urges Australians to treat retail workers with respect this Christmas season, following the launch of its online survey about abuse from customers Over the past two years, the Shop, …

A cure to your Mondayitis, let’s take a look at the funniest pharmacy-related tweets of last week ⚠️ hug a faculty of pharmacy student pls we are IN DIRE NEED …

New study provides another boost for the reach and efficacy of pharmacist influenza vaccination A wide range of Australians who would otherwise not be vaccinated against influenza would do so …

Professor Stephen King has invited community pharmacy to participate in the Review of Pharmacy Remuneration and Regulation’s financial survey of the sector. Prof King extended the invitation as the Review …

New Hepatitis C medicines a costly solution at the top of the most expensive drugs list Newly approved hepatitis C medicines have topped the latest list of the most costly …